Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-25-001096
Filing Date
2025-10-20
Accepted
2025-10-20 15:56:29
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 form5.html 5  
1 form5.xml 5 6715
  Complete submission text file 0000912282-25-001096.txt   8384
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 2477 LAKELAND FL 33806-2477
Business Address
DOCKERY CARL (Reporting) CIK: 0001618149 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38247 | Film No.: 251403773